DeviceAlliance

How is the Medical Device Business/M&A Food Chain Evolving to Cope with the Changing Business Climate?

Some say the VC model is broken. Most agree that today’s “perfect storm” of economic, regulatory and tax issues have significantly affected the ability of device start-ups to secure the resources they need to succeed.

At the same time, well established public companies (strategics) are in an ongoing competitive battle that may best be won by creating new markets through the acquisition of emerging companies.

What happens if the supply of emerging companies and products dries up? Have the strategics already begun to feel the effects? Who is going to fill the critical gap in the food chain that VCs have long held? Are new types of deals evolving? Will a new paradigm emerge?

These provocative issues will be discussed by an impressive panel of medical device executives and business leaders in what should be a thought provoking and enlightening evening.

Moderated by Rob Funsten
Bingham McCutchen LLP – Chair, Lifesciences Practice
.

Panelists include:
G.K. Kannan – Baxter International, M&A Bioscience Group
Earl Slee – Covidien (ev3), VP Strategic Business Development
Seth Yakatan – Katan Associates, Partner and Co-Founder

.

February Evening Event

Date
Tuesday, February 28, 2012

*Note: change from normal day and week

Time
5:30 – 6:30 PM – Networking
6:30 – 8:00 PM – Presentation

Heavy hors d’oeuvres and a no-host bar will be available

Location
Concordia University
1530 Concordia West, Irvine
DeNault Auditorium
Grimm Hall South 120
Map

Member Registration
2011 Members: No charge
RSVP Here

Non-Member Registration
$35 – Online
$45 – At the door (cash only)
Purchase Here

Questions
programs@devicealliance.org